New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A4944

Introduced

12/8/22

Refer

12/8/22

Caption

Authorizes medical cannabis for treatment of sickle cell anemia.

Latest NJ A4944 Activity

View All Events: NJ 2022-2023 Regular Session A4944

Companion Bills

NJ S3394

Same As Authorizes medical cannabis for treatment of sickle cell anemia.

Previously Filed As

NJ A1674

Authorizes home cultivation of medical cannabis.

NJ S1758

Authorizes home cultivation of medical cannabis.

NJ A1148

Requires four-year public institution of higher education to admit certain students diagnosed with cancer and sickle cell anemia.

NJ H0353

Sickle Cell Disease Treatment of Pain Continuing Education

NJ S3452

Establishes protection from adverse employment action for authorized medical cannabis patients.

NJ A1642

Establishes protection from adverse employment action for authorized medical cannabis patients.

NJ A1023

Requires workers' compensation, PIP, and health insurance coverage for the medical use of cannabis under certain circumstances.

NJ A1131

Authorizes cannabis cultivation on land receiving farmland assessment.

NJ A456

Makes certain changes related to application and licensing for sale of cannabis, Cannabis Regulatory Commission activity, municipal ordinances, and alternative treatment centers.

NJ A4839

Requires DHS to submit Medicaid State plan amendment to federal government requesting approval to create Health Home Program for certain Medicaid beneficiaries with sickle cell disease.

Similar Bills

No similar bills found.